title: Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery.
authors.forename: Adám
authors.initials: A
authors.lastname: Kemény-Beke
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Szekanecz
authors.forename: Sándor
authors.initials: S
authors.lastname: Szántó
authors.forename: Nóra
authors.initials: N
authors.lastname: Bodnár
authors.forename: László
authors.initials: L
authors.lastname: Módis
authors.forename: Rudolf
authors.initials: R
authors.lastname: Gesztelyi
authors.forename: Judit
authors.initials: J
authors.lastname: Zsuga
authors.forename: Péter
authors.initials: P
authors.lastname: Szodoray
authors.forename: András
authors.initials: A
authors.lastname: Berta
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018918:Phacoemulsification / Q000379:methods*; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000601:surgery*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha